Related content

VKORC1, CYP2C9 and CYP4F2 genetic-based algorithm for warfarin dosing: an Italian retrospective study

By Zambon Carlo-Federico   Pengo Vittorio   Padrini Roberto   Basso Daniela   Schiavon Stefania   Fogar Paola   Nisi Alessandra   Frigo Anna Chiara   Moz Stefania   Pelloso Michela   Plebani Mario  

Pharmacogenomics, Vol. 12, Iss. 1, 2011-01 ,pp. : 15-25

Future Medicine

Access to resources Recommend Favorite

Copy number variation and warfarin dosing: evaluation of CYP2C9, VKORC1, CYP4F2, GGCX and CALU

By Scott Stuart A   Patel Manishkumar   Martis Suparna   Lubitz Steven A   van der Zee Sarina   Yoo Chang   Edelmann Lisa   Halperin Jonathan L   Desnick Robert J  

Pharmacogenomics, Vol. 13, Iss. 3, 2012-02 ,pp. : 297-307

Future Medicine

Access to resources Recommend Favorite

Genetic determinants of warfarin dosing in the Han-Chinese population

By Lee MT Michael   Chen Chien-Hsiun   Chou Ching-Heng   Lu Liang-Suei   Chuang Hui-Ping   Chen Ying-Ting   Saleem Amir N   Wen Ming-Shien   Chen Jin-Jer   Wu Jer-Yuarn   Chen Yuan-Tsong  

Pharmacogenomics, Vol. 10, Iss. 12, 2009-12 ,pp. : 1905-1913

Future Medicine

Access to resources Recommend Favorite

Dosing algorithm for warfarin using CYP2C9 and VKORC1 genotyping from a multi-ethnic population: comparison with other equations

By Wu Alan HB   Wang Ping   Smith Andrew   Haller Christine   Drake Katherine   Linder Mark   Valdes Roland  

Pharmacogenomics, Vol. 9, Iss. 2, 2008-02 ,pp. : 169-178

Future Medicine

Access to resources Recommend Favorite

Personalised medicine with genetic-guided warfarin dosing?

By  

Inpharma, Vol. 1, Iss. 1614, 2007-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite